摘要
MDR1编码的P糖蛋白的异常表达通常与临床上导致预后不佳和化疗失败的多重抗药性有关。但是,造成后天MDR中MDR1转录和表达的精密协同机制仍然不明。在此我们证明Wnt/β连环蛋白信号路径在阿霉素引导的MDR癌细胞中被结构性激活,其中细胞核 β 连环蛋白以依靠MEK1/2/ERK1/2信号的方式特定地与转录共激活剂CBP相互作用。用RNAi介导的损耗针对性地拆除β连环蛋白和CBP可以取消导致依赖P-gp的外排作用和对阿霉素诱导细胞毒性的敏感性被完全逆转的MDR1转录和表达。此外,随着通过用特效抑制剂PD98059使MEK1/2/ERK1/2信号抑制造成β-连环蛋白和CBP相互作用的药理性中断,MDR1转录和它依赖编码P-gp的功能将消失。这些发现可以推断CBP/β连环蛋白复合体是MDR1转录增强体的核心组件。
关键词: CBP,染色体免疫沉淀反应,MDR1,p300,RNAi,Wnt/β连环蛋白
图形摘要
Current Cancer Drug Targets
Title:CBP-dependent Wnt/β-catenin signaling is crucial in regulation of MDR1 transcription
Volume: 15 Issue: 6
Author(s): Zanxian Xia, Mingquan Guo, Han Liu, Luwei Jiang, Qiaoxia Li, Jian Peng and Jia-Da Li, Baoen Shan, Pinghui Feng and Hong Ma
Affiliation:
关键词: CBP,染色体免疫沉淀反应,MDR1,p300,RNAi,Wnt/β连环蛋白
摘要: Aberrant expression of the MDR1-encoded P-glycoprotein (P-gp) is often associated with clinical multi-drug resistance (MDR) leading to poor prognosis and failure of chemotherapy. However, the precise and cooperative molecular mechanism responsible for MDR1 transcription and expression in acquired MDR remains elusive. We, herein, demonstrate that Wnt/β-catenin signal pathway is constitutively activated in Doxorubicin-induced MDR cancer cells, in which nuclear β -catenin specifically interacts with the transcriptional coactivator CBP in a MEK1/2/ERK1/2 signaldependent manner. Specific knockdown of both β-catenin and CBP by RNAi-mediated depletion abrogates MDR1 transcription and expression resulting in a complete reversal of P-gp-dependent efflux function and restoration of sensitivity to the Doxorubincin-induced cytotoxicity. Moreover, following pharmacological disruption of CBP and β - catenin interaction through inhibition of the MEK1/2/ERK1/2 signal by the specific inhibitor PD98059, MDR1 transcription and its encoded P-gp-dependent function are abolished. These findings conclude that the CBP/β-catenin complex is a core component of the MDR1 transcriptional “enhancesome”.
Export Options
About this article
Cite this article as:
Zanxian Xia, Mingquan Guo, Han Liu, Luwei Jiang, Qiaoxia Li, Jian Peng and Jia-Da Li, Baoen Shan, Pinghui Feng and Hong Ma , CBP-dependent Wnt/β-catenin signaling is crucial in regulation of MDR1 transcription , Current Cancer Drug Targets 2015; 15 (6) . https://dx.doi.org/10.2174/1568009615666150506093643
DOI https://dx.doi.org/10.2174/1568009615666150506093643 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Cellular Plasticity in Cancer Development
Current Medicinal Chemistry Current Perspectives on Anti-Aging Interventions
Letters in Drug Design & Discovery Molecular Pathogenesis of Philadelphia-Positive Chronic Myeloid Leukemia – is it all BCR-ABL?
Current Cancer Drug Targets Dietary Phytochemicals in Chemoprevention of Cancer: An Update
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The PI3K Pathway at the Crossroads of Cancer and the Immune System: Strategies for Next Generation Immunotherapy Combinations
Current Cancer Drug Targets Mapping the High Throughput SEREX Technology Screening for Novel Tumor Antigens
Combinatorial Chemistry & High Throughput Screening Novel Therapeutic Strategies Against Cancer: Marine-derived Drugs May Be the Answer?
Anti-Cancer Agents in Medicinal Chemistry Naturally Occurring NF-κB Inhibitors
Mini-Reviews in Medicinal Chemistry Tumor Stroma Manipulation By MSC
Current Drug Targets Nucleic Acids as Therapeutic Agents
Current Topics in Medicinal Chemistry Targeting Heat Shock Proteins 70/90 and Proteasome for Cancer Therapy
Current Medicinal Chemistry ROS1 Kinase Inhibitors for Molecular-Targeted Therapies
Current Medicinal Chemistry Therapeutic Applications of Mesenchymal Stem Cells: A Comprehensive Review
Current Stem Cell Research & Therapy Cancer Pharmacogenomics: Germline DNA, Tumor DNA, or Both?
Current Pharmacogenomics Thiopurines in Inflammatory Bowel Disease - The Role of Pharmacogenetics and Therapeutic Drug Monitoring
Current Pharmacogenomics Newly Identified Tumor Antigens as Promising Cancer Vaccine Targets for Malignant Melanoma Treatment
Current Topics in Medicinal Chemistry The Role of Mitochondria in Cancer Induction, Progression and Changes in Metabolism
Mini-Reviews in Medicinal Chemistry Bisacylimidoselenocarbamates Cause G2/M Arrest Associated with the Modulation of CDK1 and Chk2 in Human Breast Cancer MCF-7 Cells
Current Medicinal Chemistry Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 Diabetes and Cancer
Current Medicinal Chemistry Inflammation and Anemia
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry